Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress
Elizabeth B. Moloney, Alyssa Moskites, Eliza J. Ferrari, et al.
Neurobiology of Disease (2018) Vol. 120, pp. 1-11
Open Access | Times Cited: 103

Showing 26-50 of 103 citing articles:

Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review
Mohammad Banazadeh, Ardavan Abiri, Mohammad Mahdi Poortaheri, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130413-130413
Closed Access | Times Cited: 8
Microglia express ABI3 in the brains of Alzheimer's disease and Nasu-Hakola disease
Jun‐ichi Satoh, Yoshihiro Kino, Motoaki Yanaizu, et al.
Intractable & Rare Diseases Research (2017) Vol. 6, Iss. 4, pp. 262-268
Open Access | Times Cited: 52
Gaucher disease: Basic and translational science needs for more complete therapy and management
Gregory A. Grabowski, Armand H. Matheny Antommaria, Edwin H. Kolodny, et al.
Molecular Genetics and Metabolism (2020) Vol. 132, Iss. 2, pp. 59-75
Open Access | Times Cited: 45
Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression
Júlia Canet-Pons, Nesli-Ece Şen, Aleksandar Arsović, et al.
Neurobiology of Disease (2021) Vol. 152, pp. 105289-105289
Open Access | Times Cited: 35
Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system
Madelyn C. Houser, Oihane Uriarte Huarte, Rebecca L. Wallings, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Common genetic risk for Parkinson's disease and dysfunction of the endo-lysosomal system
Noopur Bhore, Erin C. Bogacki, Benjamin O’Callaghan, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 5
Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS
Shaochun Zhu, Anna Wuolikainen, Junfang Wu, et al.
Journal of Molecular Neuroscience (2019) Vol. 69, Iss. 4, pp. 643-657
Open Access | Times Cited: 36
Long non‐coding RNA MALAT1 regulates cell proliferation and apoptosis via miR-135b-5p/GPNMB axis in Parkinson’s disease cell model
Kefeng Lv, Yuhua Liu, Yanbing Zheng, et al.
Biological Research (2021) Vol. 54, Iss. 1
Open Access | Times Cited: 29
Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers
Firas Kobeissy, Abir Kobaisi, Wenjing Peng, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 581-581
Open Access | Times Cited: 20
Joint analysis of proteome, transcriptome, and multi-trait analysis to identify novel Parkinson’s disease risk genes
Jingjing Shi, Chengyuan Mao, Yazhou Guo, et al.
Aging (2024) Vol. 16, Iss. 2, pp. 1555-1580
Open Access | Times Cited: 4
ASO-mediated knock-down of GPNMB in mutant-GRN and in Grn-deficient peripheral myeloid cells disrupts lysosomal function and immune responses
Rebecca Wallings, Drew A. Gillett, Hannah A. Staley, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
A Mendelian randomization study on association of alpha-synuclein and GPNMB with Parkinson’s disease risk and progression
Lizhi Li, Jiabin Liu, Yige Wang, et al.
Molecular Neurobiology (2025)
Open Access
Microglia express GPNMB in the brains of Alzheimer's disease and Nasu-Hakola disease
Jun‐ichi Satoh, Yoshihiro Kino, Motoaki Yanaizu, et al.
Intractable & Rare Diseases Research (2019) Vol. 8, Iss. 2, pp. 120-128
Open Access | Times Cited: 35
Transgenic Overexpression of GPNMB Protects Against MPTP-Induced Neurodegeneration
Kevin M. Budge, Matthew L. Neal, Jason R. Richardson, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 7, pp. 2920-2933
Closed Access | Times Cited: 32
Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases
Pei‐Suen Tsou, Amr H. Sawalha
The FASEB Journal (2020) Vol. 34, Iss. 7, pp. 8810-8823
Open Access | Times Cited: 31
GPNMB mitigates Alzheimer’s disease and enhances autophagy via suppressing the mTOR signal
Zhongkang Zhu, Yuxi Liu, Xinyun Li, et al.
Neuroscience Letters (2021) Vol. 767, pp. 136300-136300
Closed Access | Times Cited: 27
Crosstalk of organelles in Parkinson’s disease – MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes
Martin Lang, Peter P. Pramstaller, Irene Pichler
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 17
Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease
Talia Krainc, Mariana H.G. Monje, Morgan Kinsinger, et al.
Movement Disorders (2022) Vol. 38, Iss. 2, pp. 185-195
Closed Access | Times Cited: 17
Shared molecular genetic factors influence subcortical brain morphometry and Parkinson’s disease risk
Luis M. García‐Marín, Paula Reyes‐Pérez, Santiago Diaz‐Torres, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Enhanced electron transfer and stability via hetero-interface engineering of MXene@MOF: Electrochemical sensors for direct detection of GPNMB in serum of PD
Yindian Wang, Wenyi Yang, Jiarong Cao, et al.
Sensors and Actuators B Chemical (2024) Vol. 417, pp. 136066-136066
Closed Access | Times Cited: 3
Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementias
Oliver Cooper, Penelope J. Hallett, Ole Isacson
FEBS Journal (2022) Vol. 291, Iss. 4, pp. 632-645
Closed Access | Times Cited: 15
Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with age
Oeystein Roed Brekk, Alyssa Moskites, Ole Isacson, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 25
Novel Results and Concepts Emerging From Lipid Cell Biology Relevant to Degenerative Brain Aging and Disease
Ole Isacson, Oeystein Roed Brekk, Penelope J. Hallett
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 25
Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease
Julia Doroszkiewicz, Agnieszka Kulczynska‐Przybik, Maciej Dulewicz, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4689-4689
Open Access | Times Cited: 7
Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease
Drew A. Gillett, Rebecca L. Wallings, Oihane Uriarte Huarte, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7

Scroll to top